GeneDx is trading at $60.92 (-4.02%) as the stock faces continued pressure from recent weak guidance and a broader selloff in technology and growth names.
- No fresh company announcements, earnings updates, or analyst actions have surfaced in the current session to explain the move.
- The stock remains volatile following recent earnings-related disappointment and heavy selling pressure in previous sessions.